Market Overview:
The global mammalian polyclonal IgG antibody market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising demand for monoclonal antibodies, and technological advancements in the field of biotechnology. Based on type, the mammalian polyclonal IgG antibody market is segmented into mouse and rabbit. The mouse segment is expected to account for a larger share of the market than the rabbit segment during the forecast period. This can be attributed to factors such as growing preference for genetically modified mice models over other animal models and increasing R&D investments in this area by pharmaceutical companies. Based on application, the mammalian polyclonal IgG antibody market is divided into cardiac polyclonal IgG antibody and metabolic polyclonal IgG antibody segments.
Product Definition:
A polyclonal antibody is an antibody that is made up of antibodies derived from multiple B cells. These antibodies are usually directed against different epitopes on the same antigen.
Mouse:
The global mouse, it's usage and growth factor in the mammalian polyclonal IgG antibody market size was valued at USD 955.5 million in 2016. It is expected to witness a CAGR of XX% during the forecast period.
Rabbit:
Rabbit and its usage in mammalian polyclonal IgG antibody market is a process through which antibodies are prepared from the blood of rabbits immunized with the antigen. The most commonly used animal source for antibody production is rabbit as it possesses the required capacity to produce high volumes of antibodies.
Application Insights:
On the basis of application, the global mammalian polyclonal IgG antibody market is segmented into cardiac polyclonal IgG antibody, metabolic polyclonal IgG antibody and metabolic monospecific IgA1 &IgA2 antibodies. The cardiac polyclonal antibodies segment dominated the overall market in terms of revenue share in 2017. This can be attributed to an increase in cardiovascular diseases that are a major cause of death globally. According to WHO, cardiovascular diseases accounted for 17% of deaths worldwide and this number is expected to rise by 70% between 2015 and 2030 globally if preventive measures are not taken against these diseases. Thus, increasing awareness about these preventable causes of mortality will drive demand for diagnostic tests which will further fuel growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D, presence of major players and their efforts for commercialization of polyclonal antibodies at a relatively lower price. Moreover, high prevalence of chronic diseases such as cancer and cardiac disorders are also contributing toward growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure & availability of medicines, rising awareness about early diagnosis & treatment options for various diseases coupled with economic development in emerging countries like China and India which has led them being one among largest markets globally for pharmaceuticals industry including biologics industry (Abbasi et al., 2016). These aforementioned factors are likely to contribute toward regional demand during the estimated time span.
Growth Factors:
- Increasing demand for monoclonal antibodies and rising investment in R&D by biopharmaceutical companies are the key growth drivers for the mammalian polyclonal IgG antibody market.
- The increasing prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases is also propelling the demand for mammalian polyclonal IgG antibodies.
- Growing awareness about the benefits of using polyclonal IgG antibodies over other types of antibodies is also fueling their demand in research laboratories and hospitals across the globe.
- Technological advancements that have made it possible to produce large quantities of high-quality mammalian polyclonal IgG antibodies are also contributing to their growth in this market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mammalian Polyclonal IgG Antibody Market Research Report
By Type
Mouse, Rabbit
By Application
Cardiac Polyclonal IgG Antibody, Metabolic Polyclonal IgG Antibody
By Companies
Polyclonal Antibody, Abcam PLC, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Merck KGaA, Cell Signalling Technologies, Inc, F. Hoffmann-La Roche Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Mammalian Polyclonal IgG Antibody Market Report Segments:
The global Mammalian Polyclonal IgG Antibody market is segmented on the basis of:
Types
Mouse, Rabbit
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiac Polyclonal IgG Antibody, Metabolic Polyclonal IgG Antibody
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Polyclonal Antibody
- Abcam PLC
- Bio-Rad Laboratories, Inc
- Thermo Fisher Scientific
- Merck KGaA
- Cell Signalling Technologies, Inc
- F. Hoffmann-La Roche Ltd.
Highlights of The Mammalian Polyclonal IgG Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mouse
- Rabbit
- By Application:
- Cardiac Polyclonal IgG Antibody
- Metabolic Polyclonal IgG Antibody
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mammalian Polyclonal IgG Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mammalian polyclonal IgG antibodies are produced by the body in response to an antigen. Mammalian polyclonal IgGs are specific to one type of protein and can be used as a diagnostic tool for detecting that particular protein in a sample.
Some of the major companies in the mammalian polyclonal igg antibody market are Polyclonal Antibody, Abcam PLC, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Merck KGaA, Cell Signalling Technologies, Inc, F. Hoffmann-La Roche Ltd..
The mammalian polyclonal igg antibody market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mammalian Polyclonal IgG Antibody Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mammalian Polyclonal IgG Antibody Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mammalian Polyclonal IgG Antibody Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mammalian Polyclonal IgG Antibody Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mammalian Polyclonal IgG Antibody Market Size & Forecast, 2020-2028
4.5.1 Mammalian Polyclonal IgG Antibody Market Size and Y-o-Y Growth
4.5.2 Mammalian Polyclonal IgG Antibody Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Mouse
5.2.2 Rabbit
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cardiac Polyclonal IgG Antibody
6.2.2 Metabolic Polyclonal IgG Antibody
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mammalian Polyclonal IgG Antibody Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mammalian Polyclonal IgG Antibody Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Mouse
9.6.2 Rabbit
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cardiac Polyclonal IgG Antibody
9.10.2 Metabolic Polyclonal IgG Antibody
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Mouse
10.6.2 Rabbit
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cardiac Polyclonal IgG Antibody
10.10.2 Metabolic Polyclonal IgG Antibody
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Mouse
11.6.2 Rabbit
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cardiac Polyclonal IgG Antibody
11.10.2 Metabolic Polyclonal IgG Antibody
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Mouse
12.6.2 Rabbit
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cardiac Polyclonal IgG Antibody
12.10.2 Metabolic Polyclonal IgG Antibody
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Mouse
13.6.2 Rabbit
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cardiac Polyclonal IgG Antibody
13.10.2 Metabolic Polyclonal IgG Antibody
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mammalian Polyclonal IgG Antibody Market: Competitive Dashboard
14.2 Global Mammalian Polyclonal IgG Antibody Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Polyclonal Antibody
14.3.2 Abcam PLC
14.3.3 Bio-Rad Laboratories, Inc
14.3.4 Thermo Fisher Scientific
14.3.5 Merck KGaA
14.3.6 Cell Signalling Technologies, Inc
14.3.7 F. Hoffmann-La Roche Ltd.
